MedTrace Logo

Pilot Study to Determine Efficacy of Cyclamen Europaeum Extract Nasal Spray in Patients With Acute Sinusitis

NCT00552773 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2013-06-04

No results posted yet for this study

Summary

To evaluate the efficacy and safety of Cyclamen europaeum extract 10 % (v/v) compared to placebo in subjects with acute sinusitis

Conditions

  • ACUTE SINUSITIS

Interventions

DRUG

Cyclamen Europaeum

Nasal spray 10% (V/V),one spray per nostril daily for 7 days.

Sponsors & Collaborators

  • Dey

    lead INDUSTRY

Principal Investigators

  • Angelique Barreto, MD · Memorial Clinical Reasearch, OK

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2008-09-30
Completion
2009-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00552773 on ClinicalTrials.gov